4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001470831-26-000179
Chief Scientific Officer gave up 2,446 shares (to pay taxes)
- Chief Scientific Officer acquired 240,000 shares (grant or award)
- Chief Scientific Officer acquired 7,050 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mahaney Paige Chief Scientific Officer | 2026-02-13 | Grant or award | +240,000 | 339,356 | D: show line 1 in the form | ||
| Mahaney Paige Chief Scientific Officer | 2026-02-14 | Option exercise | +7,050 | 339,356 | D: show line 2 in the form | ||
| Mahaney Paige Chief Scientific Officer | 2026-02-14 | Shares withheld for taxes | −2,446 | $1.89 | $4,623 | 336,910 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1771452309.xml…